Dr. Jeffrey R. Jay, M.D. »

Nektar Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2025-09-30 $17M 300k 56.90

More positions owned by Dr. Jeffrey R. Jay, M.D.

Amylyx Pharmaceuticals (AMLX)
Rezolute (RZLT)
Nektar Therapeutics (NKTR)
Zura Bio (ZURA)
Soleno Therapeutics (SLNO)
Ascendis Pharma A S (ASND)
Abivax SA F (ABVX)
Apogee Therapeutics (APGE)
Dianthus Therapeutics (DNTH)
Cytokinetics (CYTK)
Immunovant (IMVT)
Xenon Pharmaceuticals (XENE)
Neurogene (NGNE)
Eupraxia Pharmaceuticals (EPRX)
Upstream Bio (UPB)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics